Ellen Rosenberg, Chief Legal Officer at Amicus Therapeutics ($FOLD), made three open market sales of company shares over the past year, totaling about $958,000. Her most recent sale occurred on November 26, 2025. These transactions rank her 5,034th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per seller. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 13426 | $14.27 | 509,284.0000 | 308,533,548 | 2.57% | 0.00% |
| Jan. 3, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 29683 | $14.27 | 479,601.0000 | 308,533,548 | 5.83% | 0.01% |
| Nov. 25, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 36000 | $0.00 | 23,621.0000 | 308,533,548 | 60.38% | 0.01% |
| Nov. 26, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 23621 | $0.00 | 0.0000 | 308,533,548 | 100.00% | 0.01% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 25000 | $6.10 | 547,710.0000 | 308,533,548 | 4.78% | 0.01% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 11000 | $5.13 | 558,710.0000 | 308,533,548 | 2.01% | 0.00% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 36000 | $10.06 | 522,710.0000 | 308,533,548 | 6.44% | 0.01% |
| Nov. 25, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 36000 | $5.13 | 558,710.0000 | 308,533,548 | 6.89% | 0.01% |
| Nov. 25, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 36000 | $10.00 | 522,710.0000 | 308,533,548 | 6.44% | 0.01% |
| Nov. 26, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 23621 | $5.13 | 546,331.0000 | 308,533,548 | 4.52% | 0.01% |
| Nov. 26, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 23621 | $10.00 | 522,710.0000 | 308,533,548 | 4.32% | 0.01% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 25000 | $0.00 | 0.0000 | 308,533,548 | 100.00% | 0.01% |
| Nov. 24, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 11000 | $0.00 | 59,621.0000 | 308,533,548 | 15.58% | 0.00% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 64800 | $0.00 | 551,294.0000 | 300,116,081 | 13.32% | 0.02% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 28584 | $9.57 | 522,710.0000 | 300,116,081 | 5.18% | 0.01% |
| Jan. 2, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 6442 | $9.31 | 392,777.0000 | 304,380,502 | 1.61% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 112495 | $0.00 | 505,272.0000 | 304,380,502 | 28.64% | 0.04% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 15397 | $9.41 | 489,875.0000 | 304,380,502 | 3.05% | 0.01% |
| Jan. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 3381 | $9.41 | 486,494.0000 | 304,380,502 | 0.69% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Stock Options (right to buy) | 203825 | $0.00 | 203,825.0000 | 304,380,502 | 9999.99% | 0.07% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 16565 | $0.00 | 396,219.0000 | 295,164,515 | 4.36% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 12000 | $13.65 | 384,219.0000 | 295,164,515 | 3.03% | 0.00% |
| Feb. 7, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 29600 | $0.00 | 0.0000 | 295,164,515 | 100.00% | 0.01% |
| Feb. 7, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 29600 | $13.00 | 382,654.0000 | 295,164,515 | 7.18% | 0.01% |
| Feb. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 400 | $0.00 | 29,600.0000 | 295,164,515 | 1.33% | 0.00% |
| Feb. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 400 | $5.16 | 383,054.0000 | 295,164,515 | 0.10% | 0.00% |
| Feb. 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 400 | $13.00 | 382,654.0000 | 295,164,515 | 0.10% | 0.00% |
| Feb. 7, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 29600 | $5.16 | 412,254.0000 | 295,164,515 | 7.74% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 12000 | $13.65 | 382,654.0000 | 295,164,515 | 3.04% | 0.00% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 3380 | $13.44 | 394,654.0000 | 295,164,515 | 0.85% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Stock Options (right to buy) | 108980 | $0.00 | 108,980.0000 | 295,164,515 | 9999.99% | 0.04% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 30000 | $5.16 | 387,285.0000 | 295,164,515 | 8.40% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 30000 | $14.21 | 357,285.0000 | 295,164,515 | 7.75% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 63131 | $0.00 | 420,416.0000 | 295,164,515 | 17.67% | 0.02% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 6985 | $14.24 | 413,431.0000 | 295,164,515 | 1.66% | 0.00% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 15397 | $13.53 | 398,034.0000 | 295,164,515 | 3.72% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 295,164,515 | 50.00% | 0.01% |
| Dec. 27, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 5000 | $0.00 | 60,000.0000 | 289,057,198 | 7.69% | 0.00% |
| Dec. 26, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Stock Options (right to buy) | 30000 | $0.00 | 65,000.0000 | 289,057,198 | 31.58% | 0.01% |
| Dec. 27, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 5000 | $14.07 | 357,285.0000 | 289,057,198 | 1.38% | 0.00% |
| Dec. 27, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 5000 | $5.16 | 362,285.0000 | 289,057,198 | 1.40% | 0.00% |
| Dec. 26, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 30000 | $14.00 | 357,285.0000 | 289,057,198 | 7.75% | 0.01% |
| Dec. 26, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | M | Common Stock | 30000 | $5.16 | 387,285.0000 | 289,057,198 | 8.40% | 0.01% |
| Dec. 18, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 9940 | $0.00 | 357,285.0000 | 289,057,198 | 2.86% | 0.00% |
| Jan. 24, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | S | Common Stock | 31839 | $13.32 | 347,345.0000 | 289,057,198 | 8.40% | 0.01% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 24185 | $12.02 | 379,184.0000 | 289,057,198 | 6.00% | 0.01% |
| Jan. 11, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 56024 | $0.00 | 403,369.0000 | 289,057,198 | 16.13% | 0.02% |
| Jan. 4, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 3575 | $12.03 | 347,345.0000 | 289,057,198 | 1.02% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Stock Options (right to buy) | 138008 | $0.00 | 138,008.0000 | 289,057,198 | 9999.99% | 0.05% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 7893 | $11.93 | 350,920.0000 | 289,057,198 | 2.20% | 0.00% |
| Jan. 3, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | A | Common Stock | 77749 | $0.00 | 358,813.0000 | 289,057,198 | 27.66% | 0.03% |
| Jan. 2, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Rosenberg Ellen | Chief Legal Officer | F | Common Stock | 14643 | $12.21 | 281,064.0000 | 289,057,198 | 4.95% | 0.01% |